Pegylated interferon α2a induces complete remission of acute myeloid leukemia in a postessential thrombocythemia myelofibrosis permitting allogenic stem cell transplantation

Ann Hematol. 2013 Mar;92(3):407-9. doi: 10.1007/s00277-012-1560-9. Epub 2012 Sep 2.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Drug Carriers / metabolism
  • Fatal Outcome
  • Humans
  • Interferon-alpha / metabolism
  • Interferon-alpha / therapeutic use*
  • Leukemia, Myeloid, Acute / complications
  • Leukemia, Myeloid, Acute / diagnosis
  • Leukemia, Myeloid, Acute / therapy*
  • Male
  • Middle Aged
  • Polyethylene Glycols / metabolism*
  • Polyethylene Glycols / therapeutic use
  • Primary Myelofibrosis / complications
  • Primary Myelofibrosis / diagnosis
  • Primary Myelofibrosis / therapy*
  • Recombinant Proteins / metabolism
  • Recombinant Proteins / therapeutic use
  • Remission Induction
  • Stem Cell Transplantation*
  • Thrombocytosis / complications
  • Thrombocytosis / diagnosis
  • Thrombocytosis / therapy*
  • Transplantation, Homologous

Substances

  • Drug Carriers
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • peginterferon alfa-2a